Wellcome
This discussion paper examines why the ecosystem of infectious disease research and development (R&D) fails to meet people's needs and sets out potential routes for reform and key areas for discussion.
This paper looks at different stages of the ecosystem — from research priority-setting, clinical trials and regulation, manufacturing and product availability and affordability — and identifies problems, challenges and possible areas for change.
Keywords